Phage display engineered T cell receptors as tools for the study of tumor peptide-MHC interactions

Cancer immunotherapy has finally come of age, demonstrated by recent progress in strategies that engage the endogenous adaptive immune response in tumor killing. Occasionally, significant and durable tumor regression has been achieved. A giant leap forward was the demonstration that the pre-existing...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Geir Åge Løset, Gøril eBerntzen, Terje eFrigstad, Sylvie ePollmann, Kristin Støen Gunnarsen, Inger eSandlie
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Frontiers Media S.A. 2015-01-01
סדרה:	Frontiers in Oncology
נושאים:	Antigen Presentation T cell receptor MHC phage display tumor immunity immunotherapy of cancer
גישה מקוונת:	http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00378/full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!